Interviews

Future-Proofing Pharma: Transparency and Patient Focus

Yuvraj — Mon, 30 Mar 2026 12:13:37 +0000

As the pharmaceutical industry undergoes rapid digital transformation, the way brands communicate with their stakeholders is evolving at an unprecedented pace. From healthcare professionals and patients to regulators and investors, today’s audiences demand more than just information they expect transparency, personalization, and scientifically credible narratives delivered seamlessly across channels. In this dynamic landscape, marketing communications […]

The post Future-Proofing Pharma: Transparency and Patient Focus first appeared on World Pharma Today.

Harnessing AI for Biopharma Customer Engagement: A Q&A with Hemal Somaiya and Derek Choy of PharmaForceIQ

Yuvraj — Mon, 23 Mar 2026 13:00:47 +0000

While artificial intelligence (AI) has become strategically essential in commercialization and marketing, challenges in scaling and connecting piecemeal solutions have stalled adoption. In this conversation, Hemal Somaiya and Derek Choy of PharmaForceIQ share insights on how AI can help biopharma unify brand and field strategy, drive efficient execution, measure impact on business outcomes like script […]

The post Harnessing AI for Biopharma Customer Engagement: A Q&A with Hemal Somaiya and Derek Choy of PharmaForceIQ first appeared on World Pharma Today.

Redefining Drug Delivery Through Integrated Design-to-Manufacture

Yuvraj — Tue, 13 Jan 2026 05:59:21 +0000

As the pharmaceutical and MedTech industries face growing pressure to accelerate development timelines while managing increasing product complexity, the role of integrated partners has never been more critical. In this featured interview with World Pharma Today, Jason Anderson, CEO of Ensera, shares insights into how the company’s design-to-manufacture model is reshaping drug delivery and combination product […]

The post Redefining Drug Delivery Through Integrated Design-to-Manufacture first appeared on World Pharma Today.

Cyclical Saviors: Cyclodextrins and Patient-Centric Drug Design

Yuvraj — Tue, 25 Nov 2025 07:24:30 +0000

Explore how cyclodextrins in advanced biopharma delivery enhance drug stability, bioavailability, patient access and new formats for innovative treatments.

The post Cyclical Saviors: Cyclodextrins and Patient-Centric Drug Design first appeared on World Pharma Today.

Conversation with Billy Amzal, Phastar’s new Head of Strategic Consulting

Yuvraj — Thu, 21 Aug 2025 11:00:17 +0000

You’ve had a diverse career across biotech, pharma, consulting, and public health. What experiences have shaped your approach to data science and strategic consulting? I believe my training as a mathematical modeler, statistician and data scientist has given me a broad perspective. Throughout my career I have always been keen to keep learning how to […]

The post Conversation with Billy Amzal, Phastar’s new Head of Strategic Consulting first appeared on World Pharma Today.

Improving Lab Efficiency Through Equipment Utilization

Yuvraj — Mon, 21 Jul 2025 12:06:41 +0000

Q1: How can pharmaceutical laboratories quantify the financial impact when it comes to underutilized equipment in today’s constrained economic environment? What are the steps taken by Elemental Machines in this regard? A: Underutilized equipment is one of those hidden costs that doesn’t show up until you start looking closely. We’ve seen labs invest in expensive […]

The post Improving Lab Efficiency Through Equipment Utilization first appeared on World Pharma Today.

Trend Forecasting: Insights from Dr. Oliver Okle

Yuvraj — Mon, 14 Jul 2025 13:25:13 +0000

Dr. Oliver Okle is a product and service manager at Vetter The global CDMO market is projected to more than double from $161 billion in 2023 to $322.76 billion by 20331. This is only a portion of the rapid growth we’re witnessing in the broader pharmaceutical and biotech industry, driven by innovation and increased investment […]

The post Trend Forecasting: Insights from Dr. Oliver Okle first appeared on World Pharma Today.

Jason Shuris of Indero on the future of CROs & Rheumatology

content — Wed, 14 May 2025 13:36:12 +0000

Jason Shuris is the Chief Business Officer at Indero, formerly known as Innovaderm. Jason has more than 25 years of experience in the life sciences and CRO (contract research organization) sectors. His vast experience in clinical research and strategic operations has placed him at the forefront of Indero’s evolution, especially during the company’s recent rebranding […]

The post Jason Shuris of Indero on the future of CROs & Rheumatology first appeared on World Pharma Today.

Executive Interview Series with datma CEO Noah Nasser

content — Fri, 09 May 2025 13:42:38 +0000

datma is a leading provider of federated Real-World Data platforms and related tools for data analysis and visualization. datma’s mission is to empower healthcare organizations, including providers, clinicians, and researchers, to optimize their data assets, driving innovation and improving patient lives globally. Based in Oregon, the company, through its two-sided marketplace datma.FED is at the […]

The post Executive Interview Series with datma CEO Noah Nasser first appeared on World Pharma Today.

Ethical AI Investment: The Key to Sustainable Healthcare Innovation in Europe

content — Tue, 29 Apr 2025 11:00:38 +0000

In this exclusive interview, World Pharma Today sits down with Laurent Van Lerberghe and David Buller, the Managing Partners of KELES, deeply engaged in ethical AI investments, particularly within the healthcare and pharmaceutical sectors. The conversation explores their insights into the role of ethical AI in business, challenges in transparency and accountability, compliance with evolving […]

The post Ethical AI Investment: The Key to Sustainable Healthcare Innovation in Europe first appeared on World Pharma Today.